
ASTRAZENAstrazeneca Pharma India Ltd.
AstraZeneca Pharma India: Delhi High Court directs no coercive steps by NPPA
The order covers an amount of ₹151.20 crore, approximately, made up of alleged overcharged amount and interest up to 30 Oct 2026. The next hearing is listed on 11 Jan 2027.
- Order win
- pharmaceuticals












